| Tretinoin | Approved Investigational Nutraceutical | FASTK | 10922 |
downregulated | Tretinoin results in decreased expression of FASTK mRNA | 7q36.1 | |
| Tretinoin | Approved Investigational Nutraceutical | FAT1 | 2195 |
downregulated | Tretinoin results in decreased expression of FAT1 mRNA | 4q35.2 | |
| Tretinoin | Approved Investigational Nutraceutical | FAXC | 84553 |
upregulated | Tretinoin results in increased expression of FAXC mRNA | 6q16.2 | |
| Tretinoin | Approved Investigational Nutraceutical | FBN1 | 2200 |
downregulated | Tretinoin results in decreased expression of FBN1 mRNA | 15q21.1 | |
| Tretinoin | Approved Investigational Nutraceutical | FBN2 | 2201 |
downregulated | Tretinoin results in decreased expression of FBN2 mRNA | 5q23.3 | |
| Tretinoin | Approved Investigational Nutraceutical | FBP1 | 2203 |
downregulated | Tretinoin results in decreased expression of FBP1 mRNA | 9q22.32 | |
| Tretinoin | Approved Investigational Nutraceutical | FBP1 | 2203 |
upregulated | Tretinoin results in increased expression of FBP1 mRNA | 9q22.32 | |
| Tretinoin | Approved Investigational Nutraceutical | FBXL5 | 26234 |
upregulated | Tretinoin results in increased expression of FBXL5 mRNA | 4p15.32 | |
| Tretinoin | Approved Investigational Nutraceutical | FBXO34 | 55030 |
upregulated | Tretinoin results in increased expression of FBXO34 mRNA | 14q22.3 | |
| Tretinoin | Approved Investigational Nutraceutical | FBXO8 | 26269 |
downregulated | Tretinoin results in decreased expression of FBXO8 mRNA | 4q34.1 | |
| Tretinoin | Approved Investigational Nutraceutical | FBXO9 | 26268 |
upregulated | Tretinoin results in increased expression of FBXO9 mRNA | 6p12.1 | |
| Tretinoin | Approved Investigational Nutraceutical | FCER1G | 2207 |
upregulated | Tretinoin results in increased expression of FCER1G mRNA | 1q23.3 | |
| Tretinoin | Approved Investigational Nutraceutical | FCER2 | 2208 |
upregulated | Tretinoin results in increased expression of FCER2 mRNA | 19p13.2 | |
| Tretinoin | Approved Investigational Nutraceutical | FCGR2B | 2213 |
upregulated | Tretinoin results in increased expression of FCGR2B mRNA | 1q23.3 | |
| Tretinoin | Approved Investigational Nutraceutical | FCGRT | 2217 |
upregulated | Tretinoin results in increased expression of FCGRT mRNA | 19q13.33 | |
| Tretinoin | Approved Investigational Nutraceutical | FDFT1 | 2222 |
downregulated | Tretinoin results in decreased expression of FDFT1 mRNA | 8p23.1 | |
| Tretinoin | Approved Investigational Nutraceutical | FEN1 | 2237 |
downregulated | Tretinoin results in decreased expression of FEN1 mRNA | 11q12.2 | |
| Tretinoin | Approved Investigational Nutraceutical | FER1L4 | 80307 |
upregulated | Tretinoin results in increased expression of FER1L4 mRNA | 20q11.22 | |
| Tretinoin | Approved Investigational Nutraceutical | FERMT1 | 55612 |
upregulated | Tretinoin results in increased expression of FERMT1 mRNA | 20p12.3 | |
| Tretinoin | Approved Investigational Nutraceutical | FERMT2 | 10979 |
downregulated | Tretinoin results in decreased expression of FERMT2 mRNA | 14q22.1 | |
| Tretinoin | Approved Investigational Nutraceutical | FERMT3 | 83706 |
upregulated | Tretinoin results in increased expression of FERMT3 mRNA | 11q13.1 | |
| Tretinoin | Approved Investigational Nutraceutical | FES | 2242 |
upregulated | Tretinoin results in increased expression of FES mRNA | 15q26.1 | |
| Tretinoin | Approved Investigational Nutraceutical | FEZ1 | 9638 |
upregulated | Tretinoin results in increased expression of FEZ1 mRNA | 11q24.2 | |
| Tretinoin | Approved Investigational Nutraceutical | FEZF2 | 55079 |
downregulated | Tretinoin results in decreased expression of FEZF2 mRNA | 3p14.2 | |
| Tretinoin | Approved Investigational Nutraceutical | FGD2 | 221472 |
downregulated | Tretinoin results in decreased expression of FGD2 mRNA | 6p21.2 | |